Aktana

Aktana helps life science companies get the most out of artificial intelligence for commercializing their products. Its platform harnesses machine learning algorithms to enable marketing and sales teams to optimize their engagement with prescribing physicians. Aktana supports more than 100 brands and more than half the top 20 pharmaceutical companies worldwide to increase revenue, capitalize on data investments, and drive channel productivity and results.

The company’s focus on the life sciences market allows Aktana to understand and incorporate unique market dynamics more deeply than the major AI players. Headquartered in San Francisco, Aktana also has offices in New York, Philadelphia, London, Barcelona, Tokyo, Osaka, and Shanghai.

Aktana headquartered in United States, North America, operates in the Artificial Intelligence (AI), Machine Learning, Life Science, Analytics sector. The company focuses on Artificial Intelligence (AI) and has secured $12.7B in funding across 128 round(s). With a team of 251-500 employees, Aktana is actively contributing to advancements in Artificial Intelligence (AI). Their latest funding round, Series A - Aktana, raised $3.0M. Discover more about their projects, partnerships, and impact on our platform.